Editor in chief
 |
Prof. Kan Chiba, Ph.D. Chiba University, Chiba |
Associate Editors
 |
Toshihiko IkedaCPh.D. Association for Promoting Drug Development, Tokyo |
 |
Prof. Mikihisa Takano, Ph.D. Hiroshima University, Hiroshima |
 |
Ryosei Kawai, Ph.D. Novartis Institute for Biomedical Research, Inc., Cambridge, U.S.A. |
 |
Prof. Hiroshi Yamazaki, Ph.D. Showa Pharmaceutical University, Tokyo |
 |
Prof. Emi Nakashima, Ph.D. Kyoritsu University of Pharmacy, Tokyo |
 |
Prof. Hideyuki Yamada, Ph.D. Kyushu University, Fukuoka |
 |
Prof.Shogo Ozawa, Ph.D. Iwate Medical University, Iwate |
 |
Prof. Hiroaki Yuasa, Ph.D. Nagoya City University, Nagoya |
 |
Ken-ichi Sudo, Ph.D. Daiichi Sankyo Co., Ltd., Tokyo |
||
Editorial Advisory Board
Young-Nam Cha (Inha University, Incheon, Korea)
Masato Chiba (Banyu Pharmaceutical Co., Ltd., Tsukuba)
Stephen Duffull (University of Otago, New Zealand)
Yukiya Hashimoto (University of Toyama, Toyama)
Kazutaka Higaki (Okayama University, Okayama)
Masakiyo Hosokawa (Chiba Institute of Science, Chiba)
Jin-ding Huang (National Cheng Kung Univ., Taiwan)
Ichiro Ieiri (Kyushu University, Fukuoka)
Susumu Imaoka (Kwansei Gakuin University, Hyogo)
Tatsuhiro Ishida (The University of Tokushima, Tokushima)
Kiyomi Ito (Hoshi University, Tokyo)
Tomoo Itoh (Kitasato University, Tokyo)
Kazuhide Iwasaki (Pfizer Inc., Chita-gun, Aichi)
Hidefumi Kasai (Bellsystem24, Tokyo)
Motohiro Kato (Chugai Pharmaceutical Co.,Ltd., Shizuoka)
Yukio Kato (Kanazawa University, Kanazawa)
Toshiyuki Kume (Tanabe Seiyaku Co, Ltd., Saitama)
Hiroyuki Kusuhara (Tokyo University, Tokyo)
Edmund Jon Deoon Lee (National University of Singapore, Singapore)
Jiunn.H. Lin (Merck & Co., Inc., PA, USA)
Philip J. Lowe (Novartis Pharmaceuticals AG, Basel, Switzerland)
Takashi Mizuma (Tokyo University of Pharmacy and Life Sciences, Tokyo)
Teruo Murakami (Hiroshima International University, Hiroshima)
Kiyoshi Nagata (Tohoku Pharmaceutical University, Sendai)
Shinsaku Naito (Otsuka Pharmaceutical Factory, Inc., Tokushima)
Miki Nakajima (Kanazawa University, Kanazawa)
Takuo Ogihara (Takasaki University of Health and Welfare, Gunma)
R. Scott Obach (Pfizer Inc., CT, USA)
Young-Ki Paik (Yonsei University, Korea)
M. S. Roberts (Princess Alexandra Hospital, Univ. of Queensland, Australia)
Amin Rostami-Hodjegan (University of Sheffield, UK)
Chang-Koo Shim (Seoul National University, College of Pharmacy, Seoul, Korea)
Wichittra Tassaneeyakul (Departmant of Pharmacology, Facculty of Medicine, Khon kaen University, Thailand)
Akira Yamamoto (Kyoto Pharmaceutical University, Kyoto)
Fumiyoshi Yamashita (Kyoto University, Kyoto)
Bingfang Yan (University of Rhode Island, USA)
Masato Yasuhara (Tokyo Medical and Dental University, Tokyo)
Senior Advisor
Mitsuru Hashida (Kyoto University, Kyoto)
Masahiro Hayashi (School of Pharmacy, Tokyo University of Pharmacy & Life Science, Tokyo)
Nick Holford (University of Auckland, Auckland, New Zealand)
Ken-ichi Inui (Kyoto University Hospital, Kyoto)
William J. Jusko (State Univ. of New York at Buffalo, New York, USA)
Tetsuya Kamataki (Tokyo Institute of Technology and Riken, Yokohama)
Akira Tsuji (Kanazawa University, Kanazawa)
Yasushi Yamazoe (Tohoku University, Sendai)